Cover Image
市場調查報告書

家族性類澱粉沈積神經病變—(類澱粉沉積症,Corino de Andrade Disease):全球臨床實驗檢討

Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 302387
出版日期 內容資訊 英文 99 Pages
訂單完成後即時交付
價格
Back to Top
家族性類澱粉沈積神經病變—(類澱粉沉積症,Corino de Andrade Disease):全球臨床實驗檢討 Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Global Clinical Trials Review, H1, 2014
出版日期: 2014年05月15日 內容資訊: 英文 99 Pages
簡介

本報告提供家族性類澱粉沈積神經病變(FAP)相關的臨床研究最新趨勢分析,彙整疾病·治療方法概要,及主要已開發國家·新興國家的臨床實驗狀況,地區、Phase、階段別進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑等彙整資訊,為您概述為以下內容。

目錄

簡介

  • 家族性類澱粉沈積神經病變—(FAP)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東及非洲的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:代謝異常症臨床實驗數量中家族性類澱粉沈積神經病變—(FAP)的比率

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7(新興7國)臨床實驗數量:代謝異常症臨床實驗數量中家族性類澱粉沈積神經病變—(FAP)的比率

E7(新興7國)臨床實驗數量:Phase別

E7(新興7國)臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

最新臨床實驗資訊

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Pfizer Inc.
    • Alnylam Pharmaceuticals, Inc.
    • Isis Pharmaceuticals, Inc.
    • GlaxoSmithKline plc
  • 有代表性的研究機關·醫院臨床實驗概要
    • Umea University
    • 信州大學
    • Boston University
    • Ospedale Policlinico San Matteo
    • Brigham and Women's Hospital
    • 熊本大學
    • IRCCS Policlinico San Matteo

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2136CTIDB

GlobalData's clinical trial report, "Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Global Clinical Trials Review, H1, 2014" provides data on the Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease)
    • Jul 11, 2013: Alnylam Reports Positive Top-Line Results for ALN-TTRsc, a Subcutaneously Administered RNAi Therapeutic Targeting Transthyretin for the Treatment of TTR-Mediated Amyloidosis
    • Mar 18, 2013: Alnylam Initiates Phase I Clinical Study For ALN-TTRsc For Treatment Of TTR-Mediated Amyloidosis
    • Feb 19, 2013: Isis Pharma Initiates Phase II/III Study Of ISIS-TTR Rx And Earns $7.5m Milestone Payment From GlaxoSmithKline
    • Aug 06, 2012: Alnylam Pharma Presents New Preclinical Data From 'Alnylam5x15' Programs Including ALN-TTRsc For Treatment Of Transthyretin-Mediated Amyloidosis
    • Jul 16, 2012: Alnylam Reports Positive Phase I Trial Results Of ALN-TTR02 For Treatment Of TTR-Mediated Amyloidosis
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Alnylam Pharmaceuticals, Inc.
      • Clinical Trial Overview of Alnylam Pharmaceuticals, Inc.
      • Isis Pharmaceuticals, Inc.
      • Clinical Trial Overview of Isis Pharmaceuticals, Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
    • Clinical Trial Overview of Top Institutes / Government
      • Umea University
      • Clinical Trial Overview of Umea University
      • Shinshu University
      • Clinical Trial Overview of Shinshu University
      • Boston University
      • Clinical Trial Overview of Boston University
      • Ospedale Policlinico San Matteo
      • Clinical Trial Overview of Ospedale Policlinico San Matteo
      • Brigham and Women's Hospital
      • Clinical Trial Overview of Brigham and Women's Hospital
      • Kumamoto University
      • Clinical Trial Overview of Kumamoto University
      • IRCCS Policlinico San Matteo
      • Clinical Trial Overview of IRCCS Policlinico San Matteo
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Umea University, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shinshu University, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ospedale Policlinico San Matteo, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Policlinico San Matteo, 2014*

List of Figures

  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top